JP2006502230A5 - - Google Patents

Download PDF

Info

Publication number
JP2006502230A5
JP2006502230A5 JP2004543727A JP2004543727A JP2006502230A5 JP 2006502230 A5 JP2006502230 A5 JP 2006502230A5 JP 2004543727 A JP2004543727 A JP 2004543727A JP 2004543727 A JP2004543727 A JP 2004543727A JP 2006502230 A5 JP2006502230 A5 JP 2006502230A5
Authority
JP
Japan
Prior art keywords
optionally substituted
alkyl
hydrogen
phenyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004543727A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006502230A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/032318 external-priority patent/WO2004032879A2/en
Publication of JP2006502230A publication Critical patent/JP2006502230A/ja
Publication of JP2006502230A5 publication Critical patent/JP2006502230A5/ja
Pending legal-status Critical Current

Links

JP2004543727A 2002-10-11 2003-10-09 化合物、組成物および方法 Pending JP2006502230A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41803002P 2002-10-11 2002-10-11
PCT/US2003/032318 WO2004032879A2 (en) 2002-10-11 2003-10-09 Compounds, compositions, and methods

Publications (2)

Publication Number Publication Date
JP2006502230A JP2006502230A (ja) 2006-01-19
JP2006502230A5 true JP2006502230A5 (https=) 2006-11-02

Family

ID=32094139

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004543727A Pending JP2006502230A (ja) 2002-10-11 2003-10-09 化合物、組成物および方法

Country Status (5)

Country Link
US (1) US7271167B2 (https=)
EP (1) EP1558589A4 (https=)
JP (1) JP2006502230A (https=)
AU (1) AU2003300031A1 (https=)
WO (1) WO2004032879A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7625912B2 (en) 2003-12-19 2009-12-01 Merck & Co. Inc Mitotic kinesin inhibitors
EP1781674A1 (en) 2004-08-18 2007-05-09 AstraZeneca AB Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer
WO2007011721A1 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin
EP2070932A1 (en) * 2007-12-13 2009-06-17 4Sc Ag Pyrazolotriazines
EP2822931B1 (en) 2012-03-09 2017-05-03 Inception 2, Inc. Triazolone compounds and uses thereof
US8901122B2 (en) 2012-12-20 2014-12-02 Avon Products, Inc. Collagen stimulators and their use in the treatment of skin
SG11201504622PA (en) 2012-12-20 2015-07-30 Inception 2 Inc Triazolone compounds and uses thereof
CN105579440A (zh) 2013-09-06 2016-05-11 因森普深2公司 三唑酮化合物及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51125747A (en) * 1975-02-14 1976-11-02 Sumitomo Chem Co Ltd Aherbicidal and non-medical germicide
IT1057058B (it) * 1975-01-21 1982-03-10 Sumitomo Chemical Co Composti del piridiltriazinone particolaremnte utili come erbicidi e fungicidi..e procedimento per la loro preparazione
AU535319B2 (en) * 1979-12-03 1984-03-15 Sumitomo Chemical Company, Limited 1,2,4-imazine derivatives
FR2769912B1 (fr) * 1997-10-16 2000-03-10 Pf Medicament Nouveaux derives de la 3-oxo- (2h)-1,2,4 triazine leur preparation et leur application en therapeutique humaine
US20050107404A1 (en) * 2001-12-06 2005-05-19 Fraley Mark E. Mitotic kinesin inhibitors
DE10230604A1 (de) * 2002-07-08 2004-01-29 Bayer Ag Heterocyclisch substituierte Imidazotriazine

Similar Documents

Publication Publication Date Title
JP2006502230A5 (https=)
RU2005114491A (ru) Соединения, составы и способы их использования
JP6689841B2 (ja) スーパーエンハンサー領域において転写制御を標的とする方法
JP2006502219A5 (https=)
CA2413426A1 (en) Methods and compositions utilizing quinazolinones
JP2003525279A5 (https=)
DE602004001209D1 (de) Schnell wirkende pharmazeutische zusammensetzung
DE60308893D1 (de) Quinolinyl-pyrrolopyrazole
Capizzi Improvement in the therapeutic index of methotrexate (NSC-740) by L-asparaginase (NSC-109229)
TR200103302T2 (tr) Diamorfin etkin maddeli farmasötik preparat
IS8086A (is) Lyfjadreifinga kerfi
ATE489403T1 (de) Humane antikörper gegen cd40
JP2010507639A5 (https=)
SG2013013339A (en) N3 alkylated benzimidazole derivatives as mek inhibitors
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
EP2275107A3 (en) Combinations for the treatment of diseases involving cell proliferation
BR0311538A (pt) Pirazolopirimidinas
NZ269149A (en) Use of a triphenylethylene class antiestrogen to sensitize cancer cells
SE9900961D0 (sv) Novel compounds
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
CA2468314A1 (en) The use of water-soluble lamarin in the treatment of cancer
JP2005539062A5 (https=)
CN1215838C (zh) 双氯芬酸钠贴剂及其制备方法
FR2945210A1 (fr) Combinaison antitumorale comprenant l'ave8062 et le sorafenib
RU2002103865A (ru) Аминобензофеноны как ингибиторы ил-1β и TNF-α